-
The golden age of biotechnology – and why you should investSponsor Content Created With RTW Biotech Opportunities
RTW Bio offers exposure to three cutting-edge advancements in biotechnology at an attractive discount to the underlying portfolio’s valuation.
-
Three compelling healthcare stocksThree healthcare stocks, as picked by Trevor Polischuk, lead manager at the Worldwide Healthcare Trust.
-
‘Investors will sour on insurer Lemonade’AI-driven insurer Lemonade is unprofitable, and the stock looks overpriced compared with its rivals
-
Coupang shares look like a bargain – should you buy?Regulatory uncertainty and data breaches have overshadowed Coupang, a sophisticated e-commerce firm. Is it time to buy in?
-
Share tips 2026: this week’s top stock picksShare tips Share tips 2026: MoneyWeek’s roundup of the top stock picks this week – here’s what the experts think you should buy.
Share tips -
Live a little: how to cash in on the “experience economy”The experience economy is growing fast as consumers look for an alternative to their smartphones. Harry Waight explains how you can profit
-
It's time to buy the fallen market darling Judges ScientificJudges Scientific's shares have slumped, but problems at the company appear to be temporary. Should you invest in this one-of-a-kind business?
-
Who is the richest person in the world?The richest person in the world is close to becoming a trillionaire. What is their net worth?
-
Most popular investments: What did private investors buy in September?Money market funds remained popular with private investors looking for safe cash-like returns rather than riskier strategies in September, while global index funds dominated the list of most popular ETFs.
